TY - JOUR
T1 - The ER-Golgi transport of influenzavirus through NS1-Sec13 association during virus replication
AU - Chua, Sonja C.J.H.
AU - Cui, Jianzhou
AU - Sachaphibulkij, Karishma
AU - Tan, Isabelle Siang Ling
AU - Tan, Hui Qing
AU - Lim, Hong Meng
AU - Engelberg, David
AU - Lim, Lina H.K.
N1 - Publisher Copyright:
© 2023 Chua et al.
PY - 2024/1
Y1 - 2024/1
N2 - InfluenzaA virus is a respiratory virus that can cause complications such as acute bronchitis and secondary bacterial pneumonia. Drug therapies and vaccines are available against influenza,albeit limited by drug resistance and the non-universal vaccine administration. Hence there is a need for host-targeted therapies against influenzato provide an effectivealternative therapeutic target. Sec13 was identifiedas a novel host interactor of influenza.As Sec13 is a member of the nuclear pore complex and coat protein complex II (COPII) vesicles, localization of both Sec13 and non-structural protein 1 (NS1) in the nucleus, endoplasmic reticulum (ER), COPII vesicles (ER-to-Golgi transport), and Golgi was studied during infection. Sec13 is associated with ER, COPII, and Golgi in infected lung epithelial cells and not the nucleus during PR8 infection. This observation would imply the functional role of Sec13 in the COPII vesicles (ER-to-Golgi transport). Moreover, the colocalization of NS1 and Sec13 were correlated at several time points of infection, indicating the function of Sec13 during influenzainfection. Inhibiting the ER-to-Golgi transport and silencing Sec13 decreased viral titers, whereas overexpressing Sec13 increased viral titers. Hence, we propose that the ER-to-Golgi transport is an important pathway of viral replication and viral export, and specifically,Sec13 has a functional role in influenzareplication and virulence.
AB - InfluenzaA virus is a respiratory virus that can cause complications such as acute bronchitis and secondary bacterial pneumonia. Drug therapies and vaccines are available against influenza,albeit limited by drug resistance and the non-universal vaccine administration. Hence there is a need for host-targeted therapies against influenzato provide an effectivealternative therapeutic target. Sec13 was identifiedas a novel host interactor of influenza.As Sec13 is a member of the nuclear pore complex and coat protein complex II (COPII) vesicles, localization of both Sec13 and non-structural protein 1 (NS1) in the nucleus, endoplasmic reticulum (ER), COPII vesicles (ER-to-Golgi transport), and Golgi was studied during infection. Sec13 is associated with ER, COPII, and Golgi in infected lung epithelial cells and not the nucleus during PR8 infection. This observation would imply the functional role of Sec13 in the COPII vesicles (ER-to-Golgi transport). Moreover, the colocalization of NS1 and Sec13 were correlated at several time points of infection, indicating the function of Sec13 during influenzainfection. Inhibiting the ER-to-Golgi transport and silencing Sec13 decreased viral titers, whereas overexpressing Sec13 increased viral titers. Hence, we propose that the ER-to-Golgi transport is an important pathway of viral replication and viral export, and specifically,Sec13 has a functional role in influenzareplication and virulence.
KW - COPII
KW - H3N2
KW - Sec13
KW - influenza,H1N1
KW - non-structural protein 1 (NS1)
UR - http://www.scopus.com/inward/record.url?scp=85182500975&partnerID=8YFLogxK
U2 - 10.1128/spectrum.02609-23
DO - 10.1128/spectrum.02609-23
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 38038453
AN - SCOPUS:85182500975
SN - 2165-0497
VL - 12
JO - Microbiology spectrum
JF - Microbiology spectrum
IS - 1
ER -